AI assistant
CYTOKINETICS INC — Director's Dealing 2012
Sep 5, 2012
30870_dirs_2012-09-05_2b2a3c34-86fc-4c5d-89f4-35838d6eb4a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2012-09-04
Reporting Person: WOLFF ANDREW A (SVP Clinical R&D, CMO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-04 | Common Stock | M | 87500 | — | Acquired | 98750 | Direct |
| 2012-09-04 | Common Stock | F | 32052 | $0.7598 | Disposed | 66698 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-09-04 | Restricted Stock Units | $ | M | 87500 | Disposed | Common Stock (87500) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $1.05 | 2022-03-05 | Common Stock (58665) | 58665 | Direct |
| Incentive Stock Option (right to buy) | $1.57 | 2021-02-28 | Common Stock (58336) | 58336 | Direct |
| Incentive Stock Option (right to buy) | $1.85 | 2019-02-26 | Common Stock (37917) | 37917 | Direct |
| Incentive Stock Option (right to buy) | $3.08 | 2020-02-24 | Common Stock (42084) | 42084 | Direct |
| Incentive Stock Option (right to buy) | $3.37 | 2018-02-28 | Common Stock (27935) | 27935 | Direct |
| Incentive Stock Option (right to buy) | $6.59 | 2015-04-11 | Common Stock (781) | 781 | Direct |
| Incentive Stock Option (right to buy) | $6.81 | 2017-03-14 | Common Stock (14185) | 14185 | Direct |
| Incentive Stock Option (right to buy) | $7.15 | 2016-03-01 | Common Stock (17019) | 17019 | Direct |
| Incentive Stock Option (right to buy) | $9.91 | 2014-10-20 | Common Stock (40360) | 40360 | Direct |
| Non-Qualified Stock Option (right to buy) | $1.05 | 2022-03-05 | Common Stock (116335) | 116335 | Direct |
| Non-Qualified Stock Option (right to buy) | $1.57 | 2021-02-28 | Common Stock (141664) | 141664 | Direct |
| Non-Qualified Stock Option (right to buy) | $1.85 | 2019-02-26 | Common Stock (92083) | 92083 | Direct |
| Non-Qualified Stock Option (right to buy) | $3.08 | 2020-02-24 | Common Stock (92916) | 92916 | Direct |
| Non-Qualified Stock Option (right to buy) | $3.37 | 2018-02-28 | Common Stock (97065) | 97065 | Direct |
| Non-Qualified Stock Option (right to buy) | $6.59 | 2015-04-11 | Common Stock (11719) | 11719 | Direct |
| Non-Qualified Stock Option (right to buy) | $6.81 | 2017-03-14 | Common Stock (40815) | 40815 | Direct |
| Non-Qualified Stock Option (right to buy) | $7.15 | 2016-03-01 | Common Stock (42981) | 42981 | Direct |
| Non-Qualified Stock Option (right to buy) | $9.91 | 2014-10-20 | Common Stock (69640) | 69640 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of CYTK common stock at a purchase price of $0.001 per share which is the current par value of the common stock.
F2: Shares withheld by Issuer to cover taxes associated with settlement of Restricted Stock Units
F3: The restricted stock units vest in two equal annual installments. Vested shares will be delivered to the reporting person on 9/4/2012 and 9/3/2013.
F4: When the ISO and NQ dated 03/05/2012 are combined for a total grant of 175,000 shares, the option shall vest and become exercisable as to 3,645 shares on 04/05/2012 and the balance of 171,355 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/05/2016.
F5: When the ISO and NQ dated 02/28/2011 are combined for a total grant of 200,000 shares, the option shall vest and become exercisable as to 4,166 shares on 03/31/2011 and the balance of 195,834 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/28/2015.
F6: When the ISO and NQ dated 02/26/2009 are combined for a total grant of 130,000 shares, the option shall vest and become exercisable as to 2,708 shares on 03/26/09 and the balance of 127,292 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/26/13.
F7: When the ISO and NQ dated 02/24/2010 are combined for a total grant of 135,000 shares, the option shall vest and become exercisable as to 2,812 shares on 03/24/2010 and the balance of 132,188 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/24/2014.
F8: When the ISO and NQ dated 02/29/2008 are combined for a total grant of 125,000 shares, the option shall vest and become exercisable as to 2,604 shares on 03/29/08 and the balance of 122,396 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/29/12.
F9: When the ISO and NQ dated 04/11/05 are combined for a total grant of 12,500 shares, the option shall vest and become exercisable as to 12,500 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2009.
F10: When the ISO and NQ dated 03/14/2007 are combined for a total grant of 55,000 shares, the option shall vest and become exercisable as to 1,146 shares on 04/01/07 and the balance of 53,854 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/11.
F11: When the ISO and NQ dated 03/01/2006 are combined for a total grant of 60,000 shares, the option shall vest and become exercisable as to 60,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2010.
F12: When the ISO and NQ dated 10/20/04 are combined for a total grant of 110,000 shares, the option shall vest and become exercisable as to 27,500 shares on 09/20/05 and the balance of 82,500 divided into equal monthly installments thereafter such that the option shall be 100% vested on 09/20/08.